CytomX Therapeutics, Inc.
NASDAQ:CTMXBiotechnology
Healthcare
$1.88 -0.91%
-$0.03 today
- Market cap
- $409.85M
- Beta
- 2.09
- P/E (TTM)
- -8.8
- EPS (TTM)
- -$0.33
52W Low $1.72High $8.21
Volume 4.39M
Average 4.99M
Price history
CytomX Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-48.63%
Period high
$6.75
Period low
$1.88
Latest
$1.88
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| SC 13G/A | Oct 28, 2026 | Oct 28, 2026 | |
| 4/A | Oct 16, 2026 | Oct 16, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 7, 2026 | Aug 7, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| S-8 | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| 3 | Aug 5, 2026 | Aug 5, 2026 | |
| 4 | Aug 5, 2026 | Aug 5, 2026 | |
| SC 13G | Aug 3, 2026 | Aug 3, 2026 | |
| 3 | Jul 30, 2026 | Jul 30, 2026 |
Competitors
Who does CytomX Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about CTMX's filings, answered from its disclosures.
What is the latest CTMX filing?
The latest filing shown is SC 13G dated Nov 10, 2026.
How many recent filings does CTMX have?
Intrinsic Alpha currently shows 20 recent filings for CTMX.
Continue the stock analysis
Jump to another research area for this company.